Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Carnitine for prevention of postoperative atrial fibrillation after heart valve surgery
jRCTs011190012Recruiting
- Sponsor
- Japanese Association for Thoracic Surgery
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of levocarnitine in Cardiac valve disease (VHD) and Atrial fibrillation (AFib) (2 arms), sponsored by Japanese Association for Thoracic Surgery. Primary endpoint: Postoperative atrial fibrillation incidence. Started May 2020; status: recruiting.
02
Drugs
levocarnitine
03
Conditions
Cardiac valve disease (VHD)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on jRCTs011190012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs011190012.